BETASERON J Code: J1830

Self-Administered Drug Exclusion 7 Medicare Administrative Contractors list J1830 as usually self-administered and exclude it from Part B coverage in their jurisdictions. Check the article for your MAC before billing: CGS, First Coast, Noridian (A53032), Noridian (A53033), Novitas, Palmetto, Wellpoint Federal, WPS · All SAD lists →

Drug & Product Overview

HCPCS Descriptor Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

HCPCS Added Date January 1, 1982

Manufacturer Bayer Pharmaceutical

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit | Not Available

About BETASERON

Betaseron is a medication aligned to the HCPCS J Code: J1830 for billing, pricing, and reimbursement purposes in the United States. This Neurology medication is administered via the subcutaneous route and manufactured by Bayer Pharmaceutical.

Manufacturers, reach out to us to add more information.

NDC Code Information

3 NDC packages are crosswalked to J1830. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	BETASERON
	BETASERON
	BETASERON

Login to view 3 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

BETASERON Pricing & Reimbursement

J1830 Private Payer Reimbursement

$713.22 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

BETASERON CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

Not on the CMS JW / JZ list

CMS does not include Betaseron (J1830) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1830. Wastage billing guide →

BETASERON Medically Unlikely Edits (MUE)

The most billing units of J1830 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.25 mg.

Practitioner Office & Hospital Outpatient

1 unit / day

= 0.25 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

BETASERON Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease)

Frequently Asked Questions

Is there an available Betaseron billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for BETASERON.

Are there any available Betaseron patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for BETASERON.

Where can I find Betaseron prescribing information?

BETASERON prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →

Where can I find Betaseron side effect information?

Our team has not yet identified a source of side effects information for BETASERON. Please check back in a few weeks.

Does billing BETASERON require JZ/JW wastage modifiers?

CMS does not include BETASERON (J1830) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1830. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.